Related Experiment Video
Updated: Jun 27, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Infectious complications of systemic sclerosis]
Guillaume Bussone1, Alice Berezné, Luc Mouthon
1Faculté de Médecine, UPRES EA 4058, Université Paris Descartes, Paris, France.
Systemic sclerosis (SSc) patients face increased mortality, with infections causing 2-9% of deaths. Digital ulcers and immunosuppression increase infection risk, particularly in intensive care settings.
Area of Science:
- Rheumatology
- Infectious Diseases
- Critical Care Medicine
Background:
- Systemic sclerosis (SSc) is a rare autoimmune disease associated with significantly reduced survival, particularly in diffuse forms involving organ damage.
- Infections represent a notable cause of mortality in SSc patients, accounting for 2-9% of deaths.
- Limited research specifically addresses the spectrum and impact of infections in SSc.
Purpose of the Study:
- To review and summarize the current understanding of infectious complications in Systemic Sclerosis.
- To highlight patient populations and clinical scenarios with increased infection risk in SSc.
- To discuss the implications of infections on prognosis and treatment strategies in SSc.
Main Methods:
- Literature review of studies focusing on infections in Systemic Sclerosis patients.
- Analysis of reported infectious complications, including digital ulcers and opportunistic infections.
- Examination of outcomes for SSc patients with infections, particularly those requiring intensive care or undergoing transplantation.
Main Results:
- Digital ulcers are a frequent source of infectious complications in SSc.
- Patients with interstitial lung disease (ILD) on immunosuppressants are at risk for opportunistic infections, though cyclophosphamide may mitigate this risk.
- Infections in SSc patients admitted to intensive care units generally have a poor prognosis.
- Lung and hematopoietic stem cell transplantation carry a high risk of fatal infections in SSc, although recent data suggest improved outcomes post-hematopoietic stem cell transplantation.
Conclusions:
- Infections are a significant contributor to morbidity and mortality in Systemic Sclerosis.
- Vigilant monitoring and management of infections, especially in patients with digital ulcers, organ involvement, or undergoing transplantation, are crucial.
- Further research is needed to optimize the prevention and treatment of infections in the SSc population.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Endocarditis II: Clinical Features of Infective Endocarditis
Staphylococcal Skin Infections
Rocky Mountain Spotted Fever
Hypersensitivity Reactions: Immune-Complex Reactions